Ventyx Biosciences, Inc.

NasdaqGS:VTYX Stock Report

Market Cap: US$148.5m

Ventyx Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:VTYX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Apr 24SellUS$7,592Martin AusterIndividual1,405US$5.40
02 Apr 24SellUS$23,299Raju MohanIndividual4,312US$5.40
02 Apr 24SellUS$8,921John NussIndividual1,651US$5.40
02 Apr 24SellUS$8,921Christopher KruegerIndividual1,651US$5.40
20 Dec 23SellUS$124,660Raju MohanIndividual58,860US$2.12
20 Dec 23SellUS$11,210Christopher KruegerIndividual5,293US$2.12
20 Dec 23SellUS$37,334John NussIndividual17,628US$2.12

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of VTYX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,298,3513.25%
General Public3,980,4735.63%
VC/PE Firms7,102,96910%
Hedge Funds11,587,96416.4%
Institutions45,740,91064.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.8%.


Top Shareholders

Top 25 shareholders own 81.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.1%
New Science Ventures, LLC
7,102,969US$14.9m-15.8%no data
8.24%
Deerfield Management Company, L.P. Series C
5,829,570US$12.2m64.6%0.2%
8.14%
Citadel Advisors LLC
5,758,394US$12.1m-2.25%0.01%
7.42%
Capital Research and Management Company
5,247,646US$11.0m123%no data
6.75%
BlackRock, Inc.
4,771,657US$10.0m27.3%no data
4.48%
Farallon Capital Management, L.L.C.
3,170,000US$6.7m0%0.04%
4.38%
Tang Capital Management, LLC
3,100,000US$6.5m0%0.55%
4.23%
The Vanguard Group, Inc.
2,994,242US$6.3m-19.2%no data
3.38%
Octagon Capital Advisors LP
2,391,114US$5.0m59.3%0.74%
3.06%
Redmile Group, LLC
2,164,126US$4.5m0%0.21%
2.37%
Raju Mohan
1,675,028US$3.5m5.84%no data
1.95%
Goldman Sachs Group, Investment Banking and Securities Investments
1,380,779US$2.9m-17%no data
1.86%
Vestal Point Capital, LP
1,315,000US$2.8m0%0.18%
1.86%
Geode Capital Management, LLC
1,314,352US$2.8m18.8%no data
1.68%
Opaleye Management Inc.
1,190,000US$2.5m-7.39%0.36%
1.67%
State Street Global Advisors, Inc.
1,177,867US$2.5m27.1%no data
1.64%
Parkman Healthcare Partners LLC
1,160,022US$2.4m-3.98%0.29%
1.63%
Schonfeld Strategic Advisors LLC
1,153,941US$2.4m-51.3%0.02%
1.43%
Sphera Funds Management Ltd
1,012,749US$2.1m2.01%0.33%
1.13%
JP Morgan Asset Management
799,716US$1.7m0.42%no data
1.1%
Sio Capital Management, LLC
778,924US$1.6m106%0.6%
0.72%
Walleye Capital LLC
510,832US$1.1m61.7%0.01%
0.7%
Morgan Stanley, Investment Banking and Brokerage Investments
494,781US$1.0m-60.9%no data
0.67%
Jacobs Levy Equity Management Inc
475,726US$999.0k0%no data
0.66%
Charles Schwab Investment Management, Inc.
467,203US$981.1k0%no data